-+ 0.00%
-+ 0.00%
-+ 0.00%

Kintor Pharmaceutical Receives Chinese Patent Grant for KT-939

PUBT·10/30/2026 09:21:48
Listen to the news
Kintor Pharmaceutical Receives Chinese Patent Grant for KT-939
  • Kintor Pharmaceutical received a Chinese invention patent grant notice for KT-939 on Oct. 21, 2026, covering a tyrosinase inhibitor and its uses.
  • KT-939 targets the high-end cosmetic raw materials market for skin whitening and freckle removal.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kintor Pharmaceutical Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261030-12390226), on October 30, 2026, and is solely responsible for the information contained therein.